[In the Media] Association between physician characteristics and payments from industry in 2015–2017: observational study (BMJ Open, September 23, 2019)
date : 10/17/2019
U.K. academic journal the BMJ Open publishes research results from a team led by HGPI Board Member Dr. Yusuke Tsugawa.
The U.S. enacted the Physician Payment Sunshine Act in 2010 to increase transparency in the medical industry by making it mandatory for drug and medical device makers to disclose financial relationships with doctors. Since 2012, this data has been available online. A research team at UCLA analyzed payments made to 54 thousand physicians from 2015 to 2017 to identify the characteristics of physicians with strong economic ties to drug makers and similar entities.
Their research revealed that most of the payments made by drug makers and similar entities were concentrated on a small number of physicians. 73% of industry payments went to the top 1% of physicians and 91% of the payments went to the top 5%.
As for the characteristics of the physicians that received the most payments, the team discovered that male physicians, physicians with 21 to 30 years of clinical experience who form the backbone of the medical industry, and physicians who graduated from one of the top fifty medical schools had higher compensation levels. By specialty, higher payments were made to orthopaedic surgeons, neurosurgeons, and endocrinologists.
Please note that the payments referred to above are not limited to monetary payments provided to physicians. A significant portion of the payments were in the form of lunches and drinks at academic meetings, amenities such as stationery, and travel expenses. Please understand that “payments” does not only refer to cash payments like many people might imagine. However, it has been indicated that even general payments can affect what prescriptions physicians write and this is recognized as a problem in the U.S.
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session